Aclidinium bromide vs tiotropium
Non‐fatal serious adverse events · patients with stable chronic obstructive pulmonary disease
It is very uncertain whether aclidinium bromide changes non‐fatal serious adverse events compared with tiotropium (very low certainty).
1 finding from 1 review
- Aclidinium bromide for stable chronic obstructive pulmonary disease 2014 · Cochrane Headline outcomes onlyOR 0.67 [0.17, 2.65]2 studies · 729 participantsVery low